Figures & data
Table 1. Batch specification and characterization of GANP and cGANP (mean value ± S.E.M., n = 3).
Figure 1. Particle size distribution of GANP batch (n = 3).
Figure 2. Particle size distribution of cGANP batch (n = 3).
Figure 3. Zeta potential of GANP batch (n = 3).
Figure 4. Zeta potential of cGANP batch (n = 3).
Figure 5. Transmission electron microscopy of formulated nanoparticles (cGANP).
Figure 6. Overlay plot of differential scanning thermogram of polymer, drug, physical mixture and nanoparticles.
Table 2. Release kinetics of gallic acid from GANP and cGANP (mean value ± S.E.M., n = 3).
Figure 7. Cumulative percentage release from GANP and cGANP (mean ± SEM; n = 3).
Table 3. Effect of Fluoxetine, gallic acid and its formulations on immobility period for DST, TST and locomotor activity in mice.
Table 4. Effect of Fluoxetine, gallic acid and its formulations on MAO-A activity, MDA level, reduced glutathione and catalase activity in mice.